Search research articles
Contact Us
Filters
Showing results (651-660 of 799) with videos related to
Page
of 80
Sort By:
Oncotarget
|
April 8, 2017
Genetic landscape of extreme responders with anaplastic oligodendroglioma
Matthias Holdhoff, Gregory J Cairncross, Thomas M Kollmeyer, et al.
Molecular Cancer Therapeutics
|
August 31, 2019
Improved Drug Delivery to Brain Metastases by Peptide-Mediated Permeabilization of the Blood-Brain Barrier
Synnøve Nymark Aasen, Heidi Espedal, Christopher Florian Holte, et al.
JAMA
|
July 13, 2000
Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy
M H Frost, D J Schaid, T A Sellers, et al.
Cancer
|
August 10, 1999
Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors. An analysis of DNA content (ploidy), cellular proliferation, and p53 expression
A Perry, R B Jenkins, J R O'Fallon, et al.
The Journal of Urology
|
October 12, 2000
A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma
K C Halling, W King, I A Sokolova, et al.
Neuro-Oncology Practice
|
November 18, 2024
Histopathologic and molecular profile of gliomas diagnosed in Lagos, Nigeria
Lateef A Odukoya, Cristiane M Ida, Jeanette E Eckel-Passow, et al.
Prostate Cancer and Prostatic Diseases
|
October 23, 2013
A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy
A E Ross, F Y Feng, M Ghadessi, et al.
American Journal of Human Genetics
|
April 10, 2012
Resolving the breakpoints of the 17q21.31 microdeletion syndrome with next-generation sequencing
Andy Itsara, Lisenka E L M Vissers, Karyn Meltz Steinberg, et al.
Journal of the National Cancer Institute
|
November 8, 2001
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers
L C Hartmann, T A Sellers, D J Schaid, et al.
Breast Cancer Research and Treatment
|
February 20, 2013
Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005)
Edith A Perez, Michael F Press, Amylou C Dueck, et al.
Page
of 80
Search research articles
Search
Showing results (651-660 of 799) with videos related to
Sort By:
Page
of 80
Oncotarget
|
April 8, 2017
Genetic landscape of extreme responders with anaplastic oligodendroglioma
Matthias Holdhoff, Gregory J Cairncross, Thomas M Kollmeyer, et al.
Molecular Cancer Therapeutics
|
August 31, 2019
Improved Drug Delivery to Brain Metastases by Peptide-Mediated Permeabilization of the Blood-Brain Barrier
Synnøve Nymark Aasen, Heidi Espedal, Christopher Florian Holte, et al.
JAMA
|
July 13, 2000
Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy
M H Frost, D J Schaid, T A Sellers, et al.
Cancer
|
August 10, 1999
Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors. An analysis of DNA content (ploidy), cellular proliferation, and p53 expression
A Perry, R B Jenkins, J R O'Fallon, et al.
The Journal of Urology
|
October 12, 2000
A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma
K C Halling, W King, I A Sokolova, et al.
Neuro-Oncology Practice
|
November 18, 2024
Histopathologic and molecular profile of gliomas diagnosed in Lagos, Nigeria
Lateef A Odukoya, Cristiane M Ida, Jeanette E Eckel-Passow, et al.
Prostate Cancer and Prostatic Diseases
|
October 23, 2013
A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy
A E Ross, F Y Feng, M Ghadessi, et al.
American Journal of Human Genetics
|
April 10, 2012
Resolving the breakpoints of the 17q21.31 microdeletion syndrome with next-generation sequencing
Andy Itsara, Lisenka E L M Vissers, Karyn Meltz Steinberg, et al.
Journal of the National Cancer Institute
|
November 8, 2001
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers
L C Hartmann, T A Sellers, D J Schaid, et al.
Breast Cancer Research and Treatment
|
February 20, 2013
Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005)
Edith A Perez, Michael F Press, Amylou C Dueck, et al.
Page
of 80